Synbiotics for Improved Human Health: Recent Developments, Challenges, and Opportunities

Annual Review of Food Science and Technology

Volumn 9, Issue , 2018, Pages 451-479

  Krumbeck, Janina A ^a   Walter, Jens ^b   Hutkins, Robert W ^c  

^a UNIVERSITY OF NEBRASKA   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Gut health; Prebiotics; Probiotics; Synbiotics

Indexed keywords

VETERINARY MEDICINE;

CLINICAL TRIAL; COMMERCIAL APPLICATIONS; DIVERSE RANGE; GUT HEALTHS; HEALTH BENEFITS; PREBIOTICS; PROBIOTICS; SYNBIOTICS;

CLINICAL RESEARCH;

SYNBIOTIC AGENT;

CLINICAL TRIAL (TOPIC); HUMAN; INTESTINE FLORA;

CLINICAL TRIALS AS TOPIC; GASTROINTESTINAL MICROBIOME; HUMANS; SYNBIOTICS;

EID: 85044629324     PISSN: 19411413     EISSN: 19411421     Source Type: Journal    
DOI: 10.1146/annurev-food-030117-012757     Document Type: Review

References (192)

1. Abdel-Raheem S, Abd-Allah S, Hassanein K. 2012. The effects of prebiotic, probiotic and synbiotic supplementation on intestinal microbial ecology and histomorphology of broiler chickens. Int. J. Agric. Vet. Med. Sci. 6(4):277-89
2. Ahmadi A, Milani E, Madadlou A, Mortazavi SA, Mokarram RR, Salarbashi D. 2014. Synbiotic yogurt-ice cream produced via incorporation of microencapsulated Lactobacillus acidophilus (la-5) and fructooligosaccharide. J. Food Sci. Technol. 51(8):1568-74
3. Akiyama T, Kimura K, Hatano H. 2015. Diverse galactooligosaccharides consumption by bifidobacteria: implications of β-galactosidase-LacS operon. Biosci. Biotechnol. Biochem. 79(4):664-72
4. Andersen CJ, Fernandez ML. 2013. Dietary strategies to reduce metabolic syndrome. Rev. Endocr. Metab. Disord. 14(3):241-54
5. Andriulli A, Neri M, Loguercio C, Terreni N, Merla A. 2008. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study. J. Clin. Gastroenterol. 42(Suppl. 3, Part 2):S218-23
6. Angelakis E, Lagier J-C. 2016. Samples and techniques highlighting the links between obesity andmicrobiota. Microb. Pathog. 106:119-26
7. Angiolillo L, Conte A, Faccia M, Zambrini AV, Del Nobile MA. 2014. A new method to produce synbiotic Fiordilatte cheese. Innov. Food Sci. Emerg. Technol. 22:180-87
8. Aoyama M, Kotani J, Usami M. 2010. Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. Nutrition 26(6):653-61
9. Ardizzone S, Bianchi Porro G. 2005. Biologic therapy for inflammatory bowel disease. Drugs 65(16):2253-86
10. Arumugam S, Lau CSM, Chamberlain RS. 2016. Probiotics and synbiotics decrease postoperative sepsis in elective gastrointestinal surgical patients: a meta-analysis. J. Gastrointest. Surg. 20(6):1123-31
11. Asahara T, Takahashi A, Yuki N, Kaji R, Takahashi T, Nomoto K. 2016. Protective effect of a synbiotic against multidrug-resistant Acinetobacter baumannii in a murine infection model. Antimicrob. Agents Chemother. 60(5):3041-50
12. Asgharian A, Askari G, Esmailzade A, Feizi A, Mohammadi V. 2016. The effect of symbiotic supplementation on liver enzymes, C-reactive protein and ultrasound findings in patients with non-alcoholic fatty liver disease: a clinical trial. Int. J. Prev. Med. 7:59
13. Awad W, Ghareeb K, Böhm J. 2008. Intestinal structure and function of broiler chickens on diets supplemented with a synbiotic containing Enterococcus faecium and oligosaccharides. Int. J. Mol. Sci. 9(11):2205-16
14. Azcarate-Peril MA, Ritter AJ, Savaiano D, Monteagudo-Mera A, Anderson C, et al. 2017. Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals. PNAS 114(3):E367-75
15. Basturk A, Artan R, Yilmaz A. 2016. Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: a randomized controlled trial. Turk. J. Gastroenterol. 27(5):439-43
16. Belkaid Y, Hand TW. 2014. Role of the microbiota in immunity and inflammation. Cell 157(1):121-41
17. Belorkar S, Gupta A. 2016. Oligosaccharides: a boon from nature's desk. AMB Express 6:82
18. Bengmark S. 2012. Integrativemedicine and human health-the role of pre-, pro- and synbiotics. Clin. Transl. Med. 1:6
19. Beserra BTS, Fernandes R, do Rosario VA, Mocellin MC, Kuntz MG, Trindade EB. 2015. A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity. Clin. Nutr. 34(5):845-58
20. Bindels LB, Delzenne NM, Cani PD, Walter J. 2015a. Towards amore comprehensive concept for prebiotics. Nat. Rev. Gastroenterol. Hepatol. 12(5):303-10
21. Bindels LB, Neyrinck AM, Claus SP, Le Roy CI, Grangette C, et al. 2015b. Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia. ISME J. 10(6):1456-70
22. Bindels LB, Segura Munoz RR, Gomes-Neto JC, Mutemberezi V, Martínez I, et al. 2017. Resistant starch can improve insulin sensitivity independently of the gut microbiota. Microbiome 5(1):12
23. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, et al. 2003. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278(13):11312-19
24. Buffie CG, Pamer EG. 2013. Microbiota-mediated colonization resistance against intestinal pathogens. Nat. Rev. Immunol. 13(11):790-801
25. Buriti FCA, Bedani R, Saad SMI. 2016. Probiotic and Prebiotic Dairy Desserts. In Probiotics, Prebiotics, and Synbiotics: Bioactive Foods in Health Promotion, ed. RR Watson, VR Preedy, pp. 345-60. Cambridge, MA: Academic Press
26. Canavan C, West J, Card T. 2014. The epidemiology of irritable bowel syndrome. Clin. Epidemiol. 6:71-80
27. Catford JA, Jansson R, Nilsson C. 2009. Reducing redundancy in invasion ecology by integrating hypotheses into a single theoretical framework. Divers. Distrib. 15:22-40
28. Cerezuela R, Meseguer J, Esteban MA. 2011. Current knowledge in synbiotic use for fish aquaculture: a review. J. Aquac. Res. Dev. S1:008
29. Chang Y-S, Trivedi MK, Jha A, Lin YF, Dimaano L, García-Romero MT. 2016. Synbiotics for prevention and treatment of atopic dermatitis. JAMA Pediatr. 170(3):236-42
30. Charytoniuk T, Drygalski K, Konstantynowicz-Nowicka K, Berk K, Chabowski A. 2017. Alternative treatment methods attenuate the development of NAFLD: a review of resveratrolmolecular mechanisms and clinical trials. Nutrition 34:108-17
31. Chen W, Lu JX, Ding LF, Huang H, Ni YP, et al. 2016. Perioperative pro-/synbiotic for colorectal surgery: a systematic review and updated meta-analysis of randomized controlled trials. Int. J. Clin. Exp. Med. 9(6):9681-93
32. Chermesh I, Tamir A, Reshef R, Chowers Y, Suissa A, et al. 2007. Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease. Dig. Dis. Sci. 52(2):385-89
33. Chowdhury AH, Varadhan KK, Neal K, Lobo DN. 2014. Perioperative prebiotics, probiotics or synbiotics for elective abdominal surgery in adults - a systematic review and meta-analysis of randomized controlled trials. Br. J. Surg. 101:26
34. Colecchia A, Vestito A, La Rocca A, Pasqui F, Nikiforaki A, Festi D. 2006. Effect of symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Minerva Gastroenterol. Dietol. 52:349-58
35. Collado Yurrita L, San Mauro Martín I, Calle-Purón ME, Hernández Cabria M. 2014. Effectiveness of inulin intake on indicators of chronic constipation; a meta-analysis of controlled randomized clinical trials. Nutr. Hosp. 30(2):244-52
36. Cook CM, Martinez K, Leone V, Hubert N, Chang EB, Liska DJ. 2016. Prebiotic dietary fiber consumption improves glucose tolerance and modulates gastrointestinal microbiota composition in overweight/obese adults with impaired fasting glucose. FASEB J. 30(Suppl. 1):1166-63
37. Cornier M-A, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, et al. 2008. The metabolic syndrome. Endrocr. Rev. 29(7):777-822
38. Costello EK, Stagaman K, Dethlefsen L, Bohannan BJ, Relman DA. 2012. The application of ecological theory toward an understanding of the human microbiome. Science 336(6086):1255-62
39. Crittenden RC, Weerakkody R, Sanguansri L, Augustin M. 2006. Synbiotic microcapsules that enhance microbial viability during nonrefrigerated storage and gastrointestinal tract transit. Appl. Environ. Microbiol. 72:2280-82
40. Cruz-Mora J, Martínez-Hernández NE, del Campo-López FM, Viramontes-Hörner D, Vizmanos-Lamotte B, et al. 2014. Effects of a symbiotic on gut microbiota in Mexican patients with end-stage renal disease. J. Ren. Nutr. 24(5):330-35
41. Cudmore S, Doolan A, Lacey S, Shanahan F. 2017. A randomised, double-blind, placebo-controlled clinical study: the effects of a synbiotic, Lepicol, in adults with chronic, functional constipation. Int. J. Food Sci. Nutr. 68(3):366-77
42. Dang D, Zhou W, Lun ZJ, Mu X, Wang DX, Wu H. 2013. Meta-analysis of probiotics and/or prebiotics for the prevention of eczema. J. Int. Med. Res. 41(5):1426-36
43. da Silveira EA, Falco MO, Nery MW, Turchi MD. 2017. Effectiveness of nutritional treatment and synbiotic use on gastrointestinal symptoms reduction in HIV-infected patients: randomized clinical trial. Clin. Nutr. 36(3):680-85
44. Davis LMG, Martínez I, Walter J, Goin C, Hutkins RW. 2011. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLOS ONE 6(9):e25200
45. Davis LMG, Martinez I, Walter J, Hutkins R. 2010. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int. J. Food Microbiol. 144(2):285-92
46. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. 2013. The role of shortchain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54(9):2325-40
47. Deshpande G, Rao S, Patole S, Bulsara M. 2010. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125(5):921-30
48. de Vrese M, Schrezenmeir J. 2008. Probiotics, prebiotics, and synbiotics. Adv. Biochem. Eng. Biotechnol. 111:1-66
49. Dewi MR, Soenarto Y, Karyana IPG. 2015. Efficacy of synbiotic treatment in children with acute rotavirus diarrhea. Paediatr. Indones. 55(2):74-78
50. Dinleyici EC, Dalgic N, Guven S, Ozen M, Kara A, et al. 2013. The effect of a multispecies synbiotic mixture on the duration of diarrhea and length of hospital stay in children with acute diarrhea in Turkey: single blinded randomized study. Eur. J. Pediatr. 172(4):459-64
51. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. 2002. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. Br. Med. Assoc. 324:1361
52. Dughera L, Elia C, Navino M. 2007. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms. Acta Biomed. Ateneo Parm. 78(2):111-16
53. Ekhlasi G, Mohammadi RK, Agah S, Zarrati M, Hosseini AF, et al. 2016. Do symbiotic and vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial. J. Res. Med. Sci. 21:106
54. Endo Y, Shoji T, Fukudo S. 2015. Epidemiology of irritable bowel syndrome. Ann. Gastroenterol. 28:158-59
55. Eslamparast T, Zamani F, Hekmatdoost A, Sharafkhah M, Eghtesad S, et al. 2014. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study. Br. J. Nutr. 112:438-45
56. Farnworth E. 2008. The evidence to support health claims for probiotics. J. Nutr. 138:1250-54
57. Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, et al. 2002. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23(11):1953-60
58. Fernandes R, Beserra BT, Mocellin MC, Kuntz MG, da Rosa JS, et al. 2016. Effects of prebiotic and synbiotic supplementation on inflammatory markers and anthropometric indices after Roux-en-Y gastric bypass. A randomized, triple-blind, placebo-controlled pilot study. J. Clin. Gastroenterol. 50(3):208-17
59. Flint HJ, Scott KP, Louis P, Duncan SH. 2012. The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 9(10):577-89
60. Foglietta F, Serpe L, Canaparo R, Vivenza N, Riccio G, et al. 2014. Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines. J. Pharm. Pharm. Sci. 17(2):231-47
61. Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, et al. 2014. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and metaanalysis. Am. J. Gastroenterol. 109(10):1547
62. Frank DN, Pace NR. 2008. Gastrointestinal microbiology enters the metagenomics era. Gastroenterology 24(1):4-10
63. Fratianni F, Cardinale F, Russo I, Iuliano C, Tremonte P, et al. 2014. Ability of synbiotic encapsulated Saccharomyces cerevisiae boulardii to grow in berry juice and to survive under simulated gastrointestinal conditions. J. Microencapsul. 31(3):299-305
64. Fujimori S, Gudis K, Mitsui K, Seo T, Yonezawa M, et al. 2009. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition 25(5):520-25
65. Fujimori S, Tatsuguchi A, Gudis K, Kishida T, Mitsui K, et al. 2007. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease. J. Gastroenterol. Hepatol. 22(8):1199-204
66. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, et al. 2005. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54(2):242-49
67. Gagné JW, Wakshlag JJ, Simpson KW, Dowd SE, Latchman S, et al. 2013. Effects of a synbiotic on fecal quality, short-chain fatty acid concentrations, and the microbiome of healthy sled dogs. BMC Vet. Res. 9(1):246-56
68. Gao X, Zhu Y, Wen Y, Liu G, Wan C. 2016. Efficacy of probiotics in nonalcoholic fatty liver disease in adult and children: a meta-analysis of randomized controlled trials. Hepatol. Res. 46(12):1226-33
69. García-Menor E, García-Marín F, Vecino-López R, Horcajo-Martínez G, de Ibarrondo Guerrica-Echevarría MJ, et al. 2016. A multicenter, prospective, randomized controlled trial to evaluate the additional benefit of amultistrain synbiotic (Prodefen®) in the clinical management of acute viral diarrhea in children. Glob. Pediatr. Health 3:2333794X1667958
70. Ghouri YA, Richards DM, Rahimi EF, Krill JT, Jelinek KA, DuPont AW. 2014. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin. Exp. Gastroenterol. 7:473-87
71. Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, et al. 2017. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol. 11:506-14
72. Gibson GR, Roberfroid MB. 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125:1401-12
73. Gibson PR, Varney J, Malakar S, Muir JG. 2015. Food components and irritable bowel syndrome. Gastroenterology 148(6):1158-74
74. Govender M, Choonara YE, Kumar P, du Toit LC, van Vuuren S, Pillay V. 2014. A review of the advancements in probiotic delivery: conventional versus non-conventional formulations for intestinal flora supplementation. AAPS Pharm Sci Tech 15(1):29-43
75. Goyal N, Rana A, Ahlawat A, Bijjem KR, Kumar P. 2014. Animal models of inflammatory bowel disease: a review. Inflammopharmacology 22(4):219-33
76. Haller D, Antoine JM, Bengmark S, Enck P, Rijkers GT, Lenoir-Wijnkoop I. 2010. Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome. J. Nutr. 140(3):690S-97
77. Hamer HM, Jonkers DM, Venema K, Vanhoutvin SA, Troost FJ, Brummer RJ. 2008. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27(2):104-19
78. Hart ML, Suchodolski JS, Steiner JM, Webb CB. 2012. Open-label trial of a multi-strain synbiotic in cats with chronic diarrhea. J. Feline Med. Surg. 14(4):240-45
79. Hasunuma T, Kawashima K, Nakayama H, Murakami T, Kanagawa H, et al. 2011. Effect of cellooligosaccharide or synbiotic feeding on growth performance, fecal condition and hormone concentrations in Holstein calves. Anim. Sci. J. 82(4):543-48
80. He D, Wang HY, Feng JY, Zhang MM, Zhou Y, Wu XT, et al. 2013. Use of pro-/synbiotics as prophylaxis in patients undergoing colorectal resection for cancer: a meta-analysis of randomized controlled trials. Clin. Res. Hepatol. Gastroenterol. 37(4):406-15
81. Hedin C, Whelan K, Lindsay JO. 2007. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc. Nutr. Soc. 66(3):307-15
82. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, et al. 2015. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11(8):506-14
83. Hutkins RW, Krumbeck JA, Bindels LB, Cani PD, Fahey G, et al. 2016. Prebiotics: why definitions matter. Curr. Opin. Biotechnol. 37:1-7
84. Ishikawa H, Matsumoto S, Ohashi Y, Imaoka A, Setoyama H, et al. 2011. Beneficial effects of probiotic Bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study. Digestion 84(2):128-33
85. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, et al. 2013. Chronic kidney disease: global dimension and perspectives. Lancet 382(9888):260-72
86. Jonkers D. 2016. Microbial perturbations and modulation in conditions associated with malnutrition and malabsorption. Best Prac. Res. Clin. Gastroenterol. 30:161-72
87. Kasatpibal N, Whitney JD, Saokaew S, Kengkla K, Heitkemper MM, Apisarnthanarak A. 2017. Effectiveness of probiotic, prebiotic, and synbiotic therapies in reducing postoperative complications: a systematic review and network meta-analysis. Clin. Infect. Dis. 64(Suppl. 2):153-60
88. Kasubuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I. 2015. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7:2839-49
89. Katsnelson A, Writer S. 2016. Prebiotics gain prominence but remain poorly defined. PNAS 113(50):14168-69
90. Kinross JM, Markar S, Karthikesalingam A, Chow A, Penney N, et al. 2013. A meta-analysis of probiotic and synbiotic use in elective surgery: Does nutrition modulation of the gut microbiome improve clinical outcome? J. Parenter. Enter. Nutr. 37:243-53
91. Kolida S, Gibson GR. 2011. Synbiotics in health and disease. Annu. Rev. Food Sci. Technol. 2:373-93
92. Konar N, Toker OS, Oba S, Sagdic O. 2016. Improving functionality of chocolate: a review on probiotic, prebiotic, and/or synbiotic characteristics. Trends Food Sci. Technol. 49:35-44
93. Koppe L, Mafra D, Fouque D. 2015. Probiotics and chronic kidney disease. Kidney Int. 88(5):958-66
94. Korpela K, Flint H, Johnstone AM, Lappi J, Poutanen K, Dewulf E, et al. 2014. Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLOS ONE 9(3):e90702
95. Kovatcheva-Datchary P, Nilsson A, Akrami R, Lee YS, De Vadder F, et al. 2015. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab. 22:971-82
96. Krishnan S, Alden N, Lee K. 2015. Pathways and functions of gut microbiota metabolism impacting host physiology. Curr. Opin. Biotechnol. 36:137-45
97. Krumbeck JA, Maldonado-Gomez MX, Martínez I, Frese SA, Burkey TE, et al. 2015. In vivo selection to identify bacterial strains with enhanced ecological performance in synbiotic applications. Appl. Environ. Microbiol. 81(7):2455-65
98. Krumbeck JA, Maldonado-Gomez MX, Ramer-Tait AE, Hutkins RW. 2016. Prebiotics and synbiotics: dietary strategies for improving gut health. Curr. Opin. Gastroenterol. 32(2):110-19
99. Lambert JE, Parnell JA, Eksteen B, Raman M, Bomhof MR, et al. 2015. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol. BMC Gastroenterol. 15(1):169
100. Lemon KP, Armitage GC, Relman DA, Fischbach MA. 2012. Microbiota-targeted therapies: an ecological perspective. Sci. Transl. Med. 4(137):137rv5
101. Lohner S, Coughlan MT, Reid CM. 2014. Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials. Clin. Nutr. 34(5):958-65
102. Lytvyn L, Quach K, Banfield L, Johnston BC, Mertz D. 2015. Probiotics and synbiotics for the prevention of postoperative infections following abdominal surgery: a systematic review and meta-analysis of randomized controlled trials. J. Hosp. Infect. 92(2):130-39
103. Mahida YR, Rolfe VE. 2004. Host-bacterial interactions in inflammatory bowel disease. Clin. Sci. 107:331-41
104. Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. 2007. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig. Dis. Sci. 52(11):3259-65
105. Malaguarnera M, Vacante M, Antic T, Giordano M, Chisari G, et al. 2012. Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Dig. Dis. Sci. 57(2):545-53
106. Maldonado-Gómez MX, Martínez I, Bottacini F, O'Callaghan A, Ventura M, et al. 2016. Stable engraftment of Bifidobacterium longum AH1206 in the human gastrointestinal tract depends on individualized features of the resident microbiome. Cell Host Microbe 20(4):515-26
107. Mallon CA, van Elsas JD, Salles JF. 2015. Microbial invasions: the process, patterns, and mechanisms. Trends Microbiol. 23(11):719-29
108. Manzanares W, Lemieux M, Langlois PL, Wischmeyer PE. 2016. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit. Care 20(1):262-81
109. Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, et al. 2015. The gut microbiota and host health: a new clinical frontier. Gut 65(2):330-39
110. Martínez I, Kim J, Duffy PR, Schlegel VL, Walter J. 2010. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLOS ONE 5(11):e15046
111. Matijašić BB, Obermajer T, Lipoglavšek L, Sernel T, Locatelli I, et al. 2016. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: a randomized double-blind, placebo-controlled trial. J. Dairy Sci. 99(7):5008-21
112. McNeil NI. 1984. The contribution of the large-intestine to energy supplies in man. Am. J. Clin. Nutr. 39:338-42
113. Mechnikoff E. 1908. The Prolongation of Life. New York: Putnam
114. Mofidi F, Poustchi H, Yari Z, Nourinayyer B, Merat S, et al. 2017. Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial. Br. J. Nutr. 117(5):662-68
115. Molodecky NA, Soon S, Rabi DM, Ghali WA, Ferris M, et al. 2012. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142(1):46-54
116. Mugambi MN, Musekiwa A, Lombard M, Young T, Blaauw R. 2013. Association between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: a systematic review. BMC Med. Res. Methodol. 13(1):137
117. Mugambi MN, Musekiwa A, Lombard M, Young T, Blaauw R. 2012. Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review. Nutr. J. 11:81-103
118. Nikbakht E, Khalesi S, Singh I, Williams LT, West NP, Colson N. 2016. Effect of probiotics and synbiotics on blood glucose: a systematic review and meta-analysis of controlled trials. Eur. J. Nutr. In press. https://doi.org/10.1007/s00394-016-1300-3
119. Ogawa T, Asai Y, Tamai R, Makimura Y, Sakamoto H, et al. 2006. Natural killer cell activities of synbiotic Lactobacillus casei ssp. casei in conjunction with dextran. Clin. Exp. Immunol. 143(1):103-9
120. Ogawa T, Asai Y, Yasuda K, Sakamoto H. 2005. Oral immunoadjuvant activity of a new synbiotic Lactobacillus casei subsp casei in conjunction with dextran in BALB/c mice. Nutr. Res. 25(3):295-304
121. Park J-S, Lee EJ, Lee JC, Kim WK, Kim HS. 2007. Anti-inflammatory effects of short chain fatty acids in IFN-γ-stimulated RAW 264.7 murine macrophage cells: involvement of NF-κB and ERK signaling pathways. Int. Immunopharmacol. 7(1):70-77
122. Passariello A, Terrin G, Cecere G, Micillo M, Marco G, et al. 2012. Randomised clinical trial: efficacy of a new synbiotic formulation containing Lactobacillus paracasei B21060 plus arabinogalactan and xilooligosaccharides in children with acute diarrhoea. Aliment. Pharmacol. Ther. 35(7):782-88
123. Petreska-Ivanovska T, Petrushevska-Tozi L, Grozdanov A, Petkovska R, Hadjieva J, et al. 2014. From optimization of synbiotic microparticles prepared by spray-drying to development of new functional carrot juice. Chem. Ind. Chem. Eng. Q. 20(4):549-64
124. Petrof EO, Dhaliwal R, Manzanares W, Johnstone J, Cook D, Heyland DK. 2012. Probiotics in the critically ill: a systematic review of the randomized trial evidence. Crit. Care Med. 40(12):3290-302
125. Pitsouni E, Alexiou V, Saridakis V, Peppas G, Falagas ME. 2009. Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur. J. Clin. Pharmacol. 65(6):561-70
126. Preidis GA, Versalovic J. 2009. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: Gastroenterology enters the metagenomics era. Gastroenterology 136(6):2015-31
127. Puertollano E, Kolida S, Yaqoob P. 2014. Biological significance of short-chain fatty acid metabolism by the intestinal microbiome. Curr. Opin. Clin. Nutr. Metab. Care 17(2):139-44
128. Quintero-Villegas MI, Wittke A, Hutkins R. 2014. Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by lactoferrin. Curr. Microbiol. 69(4):574-79
129. Rabiei S, Shakerhosseini R, Saadat N. 2015. The effects of symbiotic therapy on anthropometric measures, body composition and blood pressure in patient with metabolic syndrome: a triple blind RCT. Med. J. Islam. Repub. Iran 29:213
130. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, et al. 2007. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 85(3):488-96
131. Rajkumar H, Kumar M, Das N, Kumar SN, Challa HR, Nagpal R. 2015. Effect of probiotic Lactobacillus salivarius UBL S22 and prebiotic fructo-oligosaccharide on serum lipids, inflammatory markers, insulin sensitivity, and gut bacteria in healthy young volunteers: a randomized controlled single-blind pilot study. J. CardiovasC. Pharmacol. Ther. 20(3):289-98
132. Raman M, Ambalam P, Kondepudi KK, Pithva S, Kothari C, et al. 2013. Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. Gut Microbes 4(3):181-92
133. Ringel-Kulka T, Kotch JB, Jensen ET, Savage E, Weber DJ. 2015. Randomized, double-blind, placebocontrolled study of synbiotic yogurt effect on the health of children. J. Pediatr. 166(6):1475-81
134. Roller M, Clune Y, Collins K, Rechkemmer G, Watzl B. 2007. Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br. J. Nutr. 97(4):676-84
135. Rossi M, Johnson DW, Morrison M, Pascoe EM, Coombes JS, et al. 2016. Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial. Clin. J. Am. Soc. Nephrol. 11(2):223-31
136. Rossi M, Klein K, Johnson DW, Campbell KL. 2012. Pre-, pro-, and synbiotics: Do they have a role in reducing uremic toxins? A systematic review and meta-analysis. Int. J. Nephrol. 2012:673631
137. Rossi R, Rossi L, Fassio F. 2015. Clinical follow-up of 96 patients affected by irritable bowel syndrome treated with a novel multi-strain symbiotic. J. Contemp. Immunol. 2(1):49-58
138. Ruan Y, Sun J, He J, Chen F, Chen R, Chen H. 2015. Effect of probiotics on glycemic control: a systematic review and meta-analysis of randomized, controlled trials. PLOS ONE 10(7):e0132121
139. Saez-Lara MJ, Gomez-Llorente C, Plaza-Diaz J, Gil A. 2015. The role of probiotic lactic acid bacteria and Bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Bio Med Res. Int. 2015:505878
140. Salonen A, Lahti L, Salojärvi J, Holtrop G, Korpela K, et al. 2014. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J. 8:2218-30
141. Sanders ME. 2015. Probiotics in 2015: their scope and use. J. Clin. Gastroenterol. 49:S2-6
142. Sartor RB. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134(2):577-94
143. Saulnier DMA. 2008. Synbiotics: making the most of probiotics by their combinations? In Food Science and Technology Bulletin: Functional Foods, Vol. 4, ed. GR Gibson, pp. 9-19. Reading, UK: Int. Food Inf. Serv.
144. Sawas T, Al Halabi S, Hernaez R, Carey WD, Cho WK. 2015. Patients receiving prebiotics and probiotics before liver transplantation develop fewer infections than controls: a systematic review andmeta-analysis. Clin. Gastroenterol. Hepatol. 13(9):1567-74
145. Serrano-Villar S, Ferrer M, Gosalbes MJ, Moreno S. 2017. Howcan the gut microbiota affect immunerecovery in HIV-infected individuals? Future Med. 12(3):195-99
146. Shen J, Zuo ZX, Mao AP. 2014. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm. Bowel Dis. 20(1):21-35
147. Shukla S, Shukla A, Mehboob S, Guha S. 2011. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment. Pharmacol. Ther. 33(6):662-71
148. Simeoli R, Raso GM, Lama A, Pirozzi C, Santoro A. 2015. Preventive and therapeutic effects of Lactobacillus paracasei B21060-based synbiotic treatment on gut inflammation and barrier integrity in colitic mice. J. Nutr. 145(6):1202-10
149. Šmid A, Strniša L, Bajc K, Vujić-Podlipec D, Matijašić BB, Rogelj I. 2016. Randomized clinical trial: the effect of fermented milk with the probiotic cultures Lactobacillus acidophilus La-5® and Bifidobacterium BB-12® and Beneo dietary fibres on health-related quality of life and the symptoms of irritable bowel syndrome in adult. J. Funct. Foods 24:549-57
150. Sonnenburg ED, Zheng H, Joglekar P, Higginbottom SK, Firbank SJ, et al. 2010. Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell 141(7):1241-52
151. Sopková D, Hertelyová Z, Andrejčáková Z, Vlčková R, Gancarčíková S, et al. 2017. The application of probiotics and flaxseed promotes metabolism of n-3 polyunsaturated fatty acids in pigs. J. Appl. Anim. Res. 45(1):93-98
152. Stecher B, Hardt W-D. 2008. The role of microbiota in infectious disease. Trends Microbiol. 16(3):107-14
153. Steed H, Macfarlane GT, Blackett KL, Bahrami B, Reynolds N. 2010. Clinical trial: the microbiological and immunological effects of synbiotic consumption-a randomized double-blind placebo-controlled study in active Crohn's disease. Aliment. Pharmacol. Ther. 32(7):872-83
154. Sun J, Buys NJ. 2016. Glucose- and glycaemic factor-lowering effects of probiotics on diabetes: a meta-analysis of randomised placebo-controlled trials. Br. J. Nutr. 115(7):1167-77
155. Suzuki T, Yoshida S, Hara H. 2008. Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability. Br. J. Nutr. 100(2):297-305
156. Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. 2014. The role of short-chain fatty acids in health and disease. Adv. Immunol. 121:91-119
157. Tanaka H, Kaneda F, Suguro R. 2004. Current system for regulation of health foods in Japan. J. Jpn. Med. Assoc. 47:436-50
158. Tanaka R, Takayama H, Morotomi M, Kuroshima T, Ueyama S. 1983. Effects of administration of TOS and Bifidobacterium breve 4006 on the human fecal flora. Bifidobact. Microflora 2(1):17-24
159. Tang Y, Chen Y, Jiang H, Robbins GT, Nie D. 2011. G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer. Int. J. Cancer 128(4):847-56
160. Tazoe H, Otomo Y, Kaji I, Tanaka R, Karaki SI, Kuwahara A. 2008. Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J. Physiol. Pharmacol. 59(Suppl. 2):251-62
161. Tedelind S, Westberg F, Kjerrulf M, Vidal A. 2007. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J. Gastroenterol. 13(20):2826-32
162. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, et al. 2012. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61(2):364-71
163. Valcheva RS, Dieleman LA. 2016. Prebiotics: definition and protective mechanisms. Best Pract. Res. Clin. Gastroenterol. 30(10):27-37
164. van den Nieuwboer M, van de Burgwal LHM, Claassen E. 2016. A quantitative key-opinion-leader analysis of innovation barriers in probiotic research and development: valorisation and improving the tech transfer cycle. Pharma Nutr. 4:9-18
165. van Loo J, Clune Y, Bennett M, Collins JK. 2005. The SYNCAN project: goals, set-up, first results and settings of the human intervention study. Br. J. Nutr. 93(Suppl. 1):S91-98
166. van Loveren H, Sanz Y, Salminen S. 2012. Health claims in Europe: probiotics and prebiotics as case examples. Annu. Rev. Food Sci. Technol. 3(1):247-61
167. van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, et al. 2014. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr. Disord. 14:9
168. Ventura M, O'Flaherty S, Claesson MJ, Turroni F, Klaenhammer TR, et al. 2009. Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat. Rev. Microbiol. 7(1):61-71
169. Verspreet J, Damen B, Broekaert WF, Verbeke K, Delcour JA, Courtin CM. 2016. A critical look at prebiotics within the dietary fiber concept. Annu. Rev. Food Sci. Technol. 7:167-90
170. Vinolo MAR, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R. 2011. Suppressive effect of shortchain fatty acids on production of proinflammatory mediators by neutrophils. J. Nutr. Biochem. 22(9):849-55
171. Virk A, Mandrekar J, Berbari EF, Boyce TG, Fischer PR, et al. 2013. A randomized, double blind, placebocontrolled trial of an oral synbiotic (AKSB) for prevention of travelers' diarrhea. J. Travel Med. 20(2):88-94
172. Vitetta L, Gobe G. 2013. Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics. Mol. Nutr. Food Res. 57(5):824-32
173. Vyas U, Ranganathan N. 2012. Probiotics, prebiotics, and synbiotics: gut and beyond. Gastroenterol. Res. Pract. 2012:872716
174. Walsh CJ, Guinane CM, O'Toole PW, Cotter PD. 2014. Beneficial modulation of the gut microbiota. FEBS Lett. 588(22):4120-30
175. Walter J, Maldonado-Gomez MX, Martinez I. 2018. To engraft or not to engraft: an ecological framework for gut microbiome modulation with live microbes. Curr. Opin. Biotechnol. 49:129-39
176. Wang H-G, Huang XD, Shen P, Li LR, Xue HT, Ji GZ, et al. 2013. Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro. Int. J. Mol. Med. 31(4):967-74
177. Wang X, Brown IL, Evans AJ, Conway PL. 1999. The protective effects of high amylose maize (amylomaize) starch granules on the survival of Bifidobacterium spp. in the mouse intestinal tract. J. Appl. Microbiol. 87(5):631-39
178. Watkinson PJ, Brown IL, Evans AJ, Conway PL. 2007. The use of pre-pro- and synbiotics in adult intensive care unit patients: systematic review. Clin. Nutr. 26(2):182-92
179. Willett WC. 2000. Diet and cancer. Oncologist 5:393-404
180. Wilms E, Gerritsen J, Smidt H, Besseling-van der Vaart I, Rijkers GT, et al. 2016. Effects of supplementation of the synbiotic Ecologic® 825/FOS P6 on intestinal barrier function in healthy humans: a randomized controlled trial. PLOS ONE 11(12):e0167775
181. Wlodarska M, Kostic AD, Xavier RJ. 2015. An integrative view of microbiome-host interactions in inflammatory bowel diseases. Cell Host Microbe 17(5):577-91
182. Wong VWS, Won GL, Chim AM, Chu WC, Yeung DK, et al. 2013. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann. Hepatol. 12(2):256-62
183. Worthley DL, Le Leu RK, Whitehall VL, Conlon M, Christophersen C, et al. 2009. A human, doubleblind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am. J. Clin. Nutr. 90(3):578-86
184. Wu M, McNulty NP, Rodionov DA, Khoroshkin MS, Griffin NW, et al. 2015. Genetic determinants of in vivo fitness and diet responsiveness in multiple human gut Bacteroides. Science 350(6256):aac5992
185. Wu X-D, Liu MM, Liang X, Hu N, Huang W. 2017. Effects of perioperative supplementation with pro-/synbiotics on clinical outcomes in surgical patients: a meta-analysis with trial sequential analysis of randomized controlled trials. Clin. Nutr. In press. doi.org/10.1016/j.clnu.2016.10.015
186. Yamamura T, Matsumoto N, Matsue Y, Okudera M, Nishikawa Y, et al. 2014. Sodium butyrate, a histone deacetylase inhibitor, regulates lymphangiogenic factors in oral cancer cell line HSC-3. Anticancer Res. 34(4):1701-8
187. Yang Z, Wu Q, Liu Y, Fan D. 2016. Effect of perioperative probiotics and synbiotics on postoperative infections after gastrointestinal surgery: a systematic review with meta-analysis. J. Parenter. Enteral. Nutr. 41:1051-62
188. Yasmin A, Butt MS, Afzaal M, van Baak M, Nadeem MT, Shahid MZ. 2015. Prebiotics, gut microbiota and metabolic risks: unveiling the relationship. J. Funct. Foods 17:189-201
189. Yu Z-T, Nanthakumar NN, Newburg DS. 2016. The human milk oligosaccharide 2′-fucosyllactose quenches Campylobacter jejuni-induced inflammation in human epithelial cells HEp-2 and HT-29 and in mouse intestinal mucosa. J. Nutr. 146:1980-90
190. Zaman SA, Sarbini SR. 2015. The potential of resistant starch as a prebiotic. Crit. Rev. Biotechnol. 36(3):578-84
191. Zhang MM, Cheng JQ, Lu YR, Yi ZH, Yang P, Wu XT. 2010. Use of pre-, pro- and synbiotics in patients with acute pancreatitis: a meta-analysis. World J. Gastroenterol. 16(31):3970-78
192. Zigra PI, Maipa VE, Alamanos YP. 2007. Probiotics and remission of ulcerative colitis: a systematic review. Neth. J. Med. 65(11):411-18